Beyond Air®

About Beyond Air®

Beyond Air® is redefining nitric oxide therapy with a new generation of cylinder-free technology. We are a commercial-stage medical device company focused on transforming how inhaled nitric oxide (iNO) is generated, delivered, and accessed. Our proprietary LungFit® platform produces unlimited, on-demand nitric oxide directly from ambient room air, eliminating the need for high-pressure gas cylinders and the logistical complexity that has accompanied iNO therapy for decades. Our first FDA-approved and CE Mark-certified product, LungFit® PH, is helping hospitals simplify respiratory care while improving operational efficiency, reducing environmental impact, and expanding access to this critical therapy. At Beyond Air, we believe innovation should remove barriers, not create them. By combining breakthrough engineering with a deep understanding of clinical workflows, we're building technologies that enable clinicians to focus less on logistics and more on patient care. As we continue to expand globally and advance the LungFit® platform, we're committed to delivering innovation that simplifies respiratory care, reduces operational burden, and supports better care for the patients who need it most.